PRECIOUS NEWS | ISSUE 5 | 12/2017
 
 
Link to website
 
 
PRECIOUS NEWS | ISSUE 5 | 12/2017
 
 

Content

Trial progress

With the last weeks of 2017 approaching, we have good news:

Royal Infirmary of Edinburgh (UK), East Tallinn Central Hospital (EE) and Sykehuset Telemark Notodden (NO) recently had their site initiation visit (SIV) and can hopefully start recruitment soon.


After their recent SIV Albertinen-Krankenhaus Hamburg (DE), Oslo University Hospital (NO),  Aeginition Hospital Athens (GR) and Royal Hallamshire Hospital  (UK) received the green light to start with PRECIOUS.


West Tallinn Central Hospital (EE), Ospedale di Città di Castello (IT), Elisabeth-TweeSteden Ziekenhuis (NL), Kings College Hospital and Nottingham University Hospital Trust (UK) have included their first patient(s).

Top 5 recruiting centers

1. University Medical Center Utrecht, NL (35 patients)

2. Haaglanden Medisch centrum, NL (10 patients)

3. ASST di Mantova, IT (6 patients)

4. Neurologische Klinik Tubingen, DE (5 patients)

5. University medical Center Hamburg – Eppendorf, DE  and Elisabeth-TweeSteden Ziekenhuis, NL (both 4 patients)

Total number of patients included: 92

We thank you for all the great work and effort you have put in PRECIOUS so far.

We wish you happy holidays and all the best for 2018!

Source: Pixabay (https://pixabay.com/)

 

 

 

Contact

Coordinator

University Medical Center Utrecht, The Netherlands
Dr. Bart van der Worp

Project Management

ARTTIC, Germany
Sophie Rau

 

Follow us on Twitter!
 
 
PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.
The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.		 Copyright | Imprint PRECIOUS has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634809.<br>The views expressed here are the responsibility of the authors only. The EU Commission takes no responsibility for any use made of the information set out.
 

If you no longer wish to receive our newsletter please click here to unsubscribe.

Having trouble viewing this email? Click here to view it in your browser.